Hi! I'm Jackie. I am currently studying Cancer Biology and hope to better my understanding and my knowledge about sequence analysis!
-
-
Welcome
Welcome to the forum, Jackie. Here is a recent open access article I thought I would mention in case you may be interested:
Title:
Methods, Challenges, and Promise of Next-Generation Sequencing in Cancer Biology
PMCID:
PMC3238319 -
Hello. I am Huimin, also new to the forum.
Thanks Joann for your suggestion.
A quick question. For RNAseq 50 bp HiSeq2000, v3 chemistry, can I ran 6 samples per lane with single end? or paired end maybe to double the # of reads? My purpose is to get the differential expression between two groups, each group 3 replicates so total 6 samples.
Thanks for your comments!Comment
-
Hi
Hi hug2001,
Welcome. For the best exposure of your technical questions to obtain a rapid response here, please be sure to post them by searching/choosing a more specific forum, such as the Illumina forum.Comment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM
Comment